Webinar

Scalp cooling & breast cancer treatment: What providers need to know

April 5, 2022
07:00pm to 08:00pm
EDT
2022-04-05 19:00:00 2022-04-05 20:00:00 America/New_York Scalp cooling & breast cancer treatment: What providers need to know  

Hair is often deeply connected with a person’s identity, so it shouldn’t be a surprise to learn that 50% of patients consider hair loss the most traumatic aspect of treatment.* 

Scalp cooling for hair preservation during chemotherapy treatment is growing in popularity and can improve your breast cancer patients’ body image and overall quality of life.

Healthcare providers play a critical role in helping their patients understand and cope with treatment side effects like hair loss, so it is important for providers to understand scalp cooling and its impact on their breast cancer patients.

During this free webinar, our speaker Elahe Salehi, DNP, ANP-BC, of Dana-Farber Cancer Institute, will share her expertise in scalp cooling.

Providers who participate in the program will understand:

  • The goals of scalp cooling and its relevance to breast cancer patients
  • How scalp cooling works and who is eligible to receive it
  • The impact of scalp cooling on hair preservation and quality of life
  • The patient and provider experience
  • Costs and resources associated with scalp cooling
  • Best practices for health systems

Presenation slides

Q&A with our speakers

We are unable to offer CEs for this program. However, certificates of participation will be available upon request through the evaluation process.

About our speaker

Elahe Salehi, DNP, ANP-BCElahe Salehi, DNP, ANP-BC 
Nurse Practitioner, Department of Breast Oncology 
Director of Advanced Practice Nursing, Division of Women’s Cancers  
Dana-Farber Cancer Institute, Boston MA 

Elahe Salehi, DNP, ANP-BC, is currently working as an oncology nurse practitioner for the Department of Breast Oncology. Her research focuses on improving the experience and safety of receiving cancer-directed therapies, with a focus on reducing toxicity and improving quality of life. She has designed and implemented Scalp Cooling Best Practice Guidelines and Policies at DFCI and is the Principal Investigator of DFHCC trial 21-169 (Assessing the Impact of Scalp Cooling in Patients with Metastatic Breast Cancer). Read more.

Elahe will be joined by Richard Paxman, CEO of Paxman Scalp Cooling, for a brief introduction and for the Q&A portion of the program. 

If you’re interested in hearing more about scalp cooling from the patient perspective, check out our blog post about What to expect from scalp cooling


*Nangia J, Wang T, Osborne C, Niravath P, Otte K, Papish S, Holmes F, Abraham J, Lacouture M, Courtright J, Paxman R, Rude M, Hilsenbeck S, Osborne CK, Rimawi M. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial. JAMA. 2017 Feb 14;317(6):596-605. doi: 10.1001/jama.2016.20939. PMID: 28196254.
Event Sponsors